Bernardo Kanahuati is a global pharmaceutical leader, currently serving as Senior Vice President at Bayer, where he leads the global Cardiorenal franchise. His extensive international career includes roles as CEO for Iberia and General Manager for Mexico. He earned an MBA from ESADE/NYU Stern Business Schools and has completed executive programs at Harvard and IMD.
Outside of his corporate responsibilities, Bernardo is a vocal advocate for heart health, actively participating in public awareness campaigns like the #BeatsChallenge for World Heart Day. He often speaks on the importance of collaborative and open innovation to solve societal challenges in health and nutrition. He has a personal interest in taking long walks for fitness.
He is passionate about the "biorevolution, " a convergence of science, data, and technology to cure diseases and create sustainable agriculture.
Read the full overview →They choose to analyze logically and value facts to emotions. It is very likely that they will negotiate pricing or other important terms. Unless the value is proven by data, they are unlikely to value fancy features.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.